Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors

被引：0

作者：

Onali, S. ^{[1
]}

Pugliese, D. ^{[2
,3
,4
]}

Caprioli, F. A. ^{[5
,6
,7
]}

Orlando, A. ^{[8
]}

Biancone, L. ^{[9
]}

Nardone, O. M. ^{[10
]}

Imperatore, N. ^{[11
]}

Fiorino, G. ^{[12
]}

Cappello, M. ^{[13
]}

Viola, A. ^{[14
]}

Principi, M. B. ^{[15
]}

Bezzio, C. ^{[16
]}

Aratari, A. ^{[17
]}

Carparelli, S. ^{[18
]}

Mazzuoli, S. ^{[19
]}

Manguso, F. ^{[11
]}

Grossi, L. ^{[20
]}

Bodini, G. ^{[21
]}

Ribaldone, D. ^{[22
]}

Mocci, G. ^{[23
]}

Minerba, L. ^{[24
]}

Favale, A. ^{[25
]}

Grova, M. ^{[26
]}

Scucchi, L. ^{[27
]}

Segato, S. ^{[28
]}

Fries, W. ^{[29
]}

Castiglione, F. ^{[30
]}

Armuzzi, A.

Fantini, M. C. ^{[31
]}

机构：

[1] Univ Cagliari, Sci Med Sanita Pubbl, Cagliari, Italy

[2] Univ Cattolica Sacro Cuore, CEMAD IBD UNIT, Unita Operat Complessa Med Interna & Gastro, Dipartimento Sci Med Chirurg, Rome, Italy

[3] Univ Gemelli IRCCS, Fdn Policlin, Rome, Italy

[4] Univ Cattolica Sacro Cuore, Dipartimento Univ Med Chirurg Traslaz, Rome, Italy

[5] Univ Milan, Milan, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore Policli, Gastroenterol & Endoscopy Unit, Milan, Italy

[7] Dept Pathophysiol & Transplantat, Milan, Italy

[8] IBD UNIT Villa Sofia Cervello Hosp, Ibd unit, Palermo, Italy

[9] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy

[10] AOU Federico II, Dept Clin Med & Surg, Naples, Italy

[11] AORN Cardarell, Gastroenterol & Endoscopy Unit, Naples, Italy

[12] Humanitas Univ Pieve Emanuele, Dept Biomed Sci, Milan, Italy

[13] Univ Palermo Sicily Italy, IBD Clin Gastroenterol Sect Promise, Palermo, Italy

[14] Univ Messina Italy, IBD Unit Dept Clin & Expt Med, Messina, Italy

[15] Policlin Univ Bari Italy, Gastroenterol Sect DETO, Bari, Italy

[16] Asst Rhodense Rho Milan Italy, Gastroenterol Unit, Milan, Italy

[17] Ospedale San Filippo Neri, Unita operat semplice IBD, Rome, Italy

[18] Fdn Casa Sollievo Sofferenza IRCCS San G, UOC Gastroenterol Endoscopia Digest, San Giovanni Rotondo, Italy

[19] Mons Raffaele Dimiccoli Barletta Italy, UOC Gastroenterol, Barletta, Italy

[20] Gd Annunzio Univ DSMOB Osped Spirito Santo Pesc, Gastroenterol Unit, Pescara, Italy

[21] Univ Genoa, Gastroenterol Units, Policlin San Martino, Genoa, Italy

[22] Univ Torino, Dipartimento Sci Med, Turin, Italy

[23] G Brotzu Cagliari Italy, Gastroenterol ARNAS, Cagliari, Italy

[24] Univ Cagliari, Dip Stat Med, Cagliari, Italy

[25] Univ Cagliari, UOC Gastroenterol, Cagliari, Italy

[26] Villa Sofia Cervello Hosp Italy, IBD unit, Palermo, Italy

[27] Univ Rome Tor Vergata Italy, Dept Syst Med, Rome, Italy

[28] Osped Circolo & Fdn Macchi, Gastroenterol Endoscopia Digest, Varese, Italy

[29] Univ Messina Italy, IBD Unit, Dept Clin & Expt Med, Messina, Italy

[30] AOU Federico II Napoli Italy, Gastroenterol Dept Clin Med & Surg, Naples, Italy

[31] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P613

引用

页码：I542 / I543

页数：2

共 50 条

[1] COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN'S DISEASE PATIENTS FAILURE TO TNF INHIBITORS
Onali, S.
Pugliese, D.
Caprioli, F. A.
Orlando, A.
Biancone, L.
Nardone, O. M.
Imperatore, N.
Fiorino, G.
Cappello, M.
Viola, A.
Principi, M. B.
Bezzio, C.
Aratari, A.
Carparelli, S.
Mancuso, F.
Grossi, L.
Bodini, G.
Ribaldone, D.
Mocci, G.
Favale, A.
Grova, M.
Scucchi, L.
Segato, S.
Fries, W.
Castiglione, F.
Armuzzi, A.
Fantini, M. C.
[J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 : S140 - S141
[2] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
Onali, S.
Pugliese, D.
Caprioli, F. A.
Orlando, A.
Biancone, L.
Nardone, O. M.
Imperatore, N.
Fiorino, G.
Cappello, M.
Viola, A.
Principi, M. B.
Bezzio, C.
Aratari, A.
Carparelli, S.
Mazzuoli, S.
Manguso, F.
Grossi, L.
Bodini, G.
Ribaldone, D.
Mocci, G.
Minerba, L.
Favale, A.
Grova, M.
Scucchi, L.
Segato, S.
Fries, W.
Castiglione, F.
Armuzzi, A.
Fantini, M. C.
[J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
[3] An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
Onali, Sara
Pugliese, Daniela
Caprioli, Flavio Andrea
Orlando, Ambrogio
Biancone, Livia
Nardone, Olga Maria
Imperatore, Nicola
Fiorino, Gionata
Cappello, Maria
Viola, Anna
Principi, Maria Beatrice
Bezzio, Cristina
Aratari, Annalisa
Carparelli, Sonia
Mazzuoli, Silvia
Manguso, Francesco
Grossi, Laurino
Bodini, Giorgia
Ribaldone, Davide
Mocci, Giammarco
Miranda, Agnese
Minerba, Luigi
Favale, Agnese
Grova, Mauro
Scucchi, Ludovica
Segato, Simone
Fries, Walter
Castiglione, Fabiana
Armuzzi, Alessandro
Fantini, Massimo C.
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (08): : 1279 - 1287
[4] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
Rullan, M.
Elosua, A.
Saldana, C.
Amorena, E.
Vicuna, M.
Rubio, S.
Nantes, O.
Rodriguez, C.
[J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S453 - S454
[5] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
Sanchez Rodriguez, E.
Mesonero Gismero, F.
Lopez Sanroman, A.
[J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S590 - S591
[6] Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)
Biemans, V.
van der Woude, C.
van der Meulen-de Jong, A.
Dijkstra, G.
de Boer, N.
Oldenburg, B.
Ponsioen, C.
de Vries, A.
Wintjens, D.
Hoentjen, F.
Pierik, M.
[J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S66 - S67
[7] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
Kappelman, Michael
Lewis, James D.
Zhang, Xian
Lin, Feng-Chang
Weisbein, Laura
Chen, Wenli
Burris, Jessica L.
Dorand, Jennifer E.
Parlett, Lauren E.
Haynes, Kevin
Nair, Vinit
Kaul, Alan F.
Dobes, Angela
Long, Millie
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
[8] Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn's disease
Dussias, N.
Rizzello, F.
Calabrese, C.
Passino, A. Sanna
Melotti, L.
Scaioli, E.
Belluzzi, A.
Gionchetti, P.
[J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S528 - S528
[9] COMPARATIVE SAFETY AND EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY CROHN'S DISEASE PATIENTS
Gebeyehu, Gerum Gashaw
Fiske, Joseph
Liu, Eleanor
Limdi, Jimmy
Davies, Mike
Baig, Daniyal
Liaros, Angela
Gaba, Waqas
Smith, Philip
Subramanian, Sreedhar
[J]. GUT, 2022, 71 : A47 - A48
[10] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
Sharip, Mohmmed Tauseef
Nishad, Nilanga
Pillay, Lushen
Goordoyel, Nilkantsingh
Goerge, Samuel
Subramanian, Sreedhar
[J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)

← 1 2 3 4 5 →